Nature of Business and Liquidity (Details)	1 Months Ended	6 Months Ended
	Aug. 31, 2015 USD ($) $ / shares shares	Jun. 30, 2016 USD ($) item	Dec. 31, 2015 USD ($)
Sales of Stock
Accumulated deficit		$ 33,090,818	$ 22,580,055
Number of Phase 2 Studies
Number of Phase 2 Studies with sufficient cash to fund operations | item		5
IPO
Sales of Stock
Shares issued | shares	3,450,000
Offering price per share | $ / shares	$ 14.00
Net proceeds	$ 42,100,000